Perfluorinated fatty acids (PFCAs), straight chain fatty acid analogues of which all aliphatic hydrogens are substituted with fluorine are primarily used as industrial materials, because of their surfactant properties, and their chemical and thermal stability. 1) Of PFCAs, perfluorooctanoic acid (PFOA) was the most widely used as a reactive intermediate in the industrial synthesis of fluoroacrylic esters, and its salts are used as processing aids in the production of fluoropolymer and fluoroelastmers and in other surfactant use. Since PFOA does not undergo biotransformation 2) and accumulates in the environment, [3] [4] [5] PFOA is found in the serum of not only occupationally exposed workers, 6) but also general populations. 7, 8) In this respect, most efforts have been made to study biological and hazardous effects of PFOA in particular, 9) so that toxicological information pertaining to PFCAs is limited largely to PFOA.
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The previous studies showed that administration of PFOA markedly induced peroxisomal b-oxidation in the liver of male rats, whereas the induction was observed in female rats to an extremely less extent. 10, 11) The subsequent study using rats as experimental animals showed that a sex-related difference in the induction by perfluorononanonic acid (PFNA) and perfluoroheptanoic acid (PFHA) was significant whereas the extent was not so striking as that by PFOA and that perfluorodecanoic acid (PFDA) markedly induced peroxisomal b-oxidation without sex-related difference. 12) When compared the potency to induce peroxisomal b-oxidation by among PFHA, PFOA, PFNA and PFDA in the liver of male rats, the potency of the induction has been shown to be in the order of PFHAϽPFOAϽPFNAՅPFDA. 12) On the basis of the findings from in vitro experiments employing rat hepatocytes, it is likely that the extent of the induction of peroxisomal b-oxidation by PFCAs depends on only concentration of PFCA molecules rather than the difference in their perfluoroalkyl chain length. 12, 13) Differed from the case of rats, the administration of PFOA to female mice has been shown to markedly induce peroxisomal b-oxidation in the liver to the extent comparable to that of male mice. 11, 14) However, no explanation has been made for the mechanism responsible for this observation. Moreover, little information is available about biological effect of PFCAs other than PFOA in the liver of mice. These facts stimulate our interest in studying the response of the liver to PFCAs with different perfluoroalkyl chain lengths.
The specific goals of the present study are to ascertain (i) whether there exists perfluoroalkyl chain length-related difference in response of the liver of mice to PFCAs employing inductions of hepatomegaly, peroxisomal b-oxidation and microsomal 1-acylglycerophosphocholine (1-acyl-GPC) acyltransferase as parameters; (ii) the reason why there is no difference in the response of hepatic peroxisomal b-oxidation to PFOA in male and female mice; and (iii) whether there is sex-related difference in the response of hepatic peroxisomal b-oxidation to perfluorohexanoic acid (PFHeA), PFHA and PFNA.
MATERIALS AND METHODS

Materials
Palmitoyl-CoA, oleoyl-CoA, bovine serum albumin (essentially fatty acid free), PFHeA, PFHA, and PFOA were purchased from Sigma Aldrich Japan (Tokyo, Japan). PFNA was from Lancaster Synthesis (Lancashire, U.K.); CoA and nicotinamide adenine dinucleotide were from Oriental Yeast Co. (Tokyo, Japan); 1-acyl-GPC was from Avanti Polar Lipid (Pelham, AL, U.S.A). 3-Bromoacetyl-7-methoxycoumarin was prepared as described previously. 15) Animals and Treatments Male and female ddY mice aged 7 weeks were purchased from SLC (Hamamatsu, Japan). After 1 week of acclimatization, mice were intraperitoneally administered with PFCAs at the doses ranging from 50 to 150 mg/kg of body weight for PFHeA, 25 to 100 mg/kg of body weight for PFHA, and 2.5 to 20 mg/kg of body weight for PFOA and PFNA. PFCAs were dissolved in propyleneglycol : water (1 : 1, v/v) after neutralization with 1 M NaOH. Mice were killed under diethyl ether anesthesia. Livers were excised, perfused with ice-cold 0.9% NaCl. Liver was homogenized with 4 volumes of 0.25 M sucrose/ 1 mM EDTA/10 mM Tris-HCl (pH 7.4) in a Potter glassTeflon homogenizer. An aliquot of the homogenates was frozen in liquid nitrogen and stored at Ϫ80°C for determination of PFCAs and for assay for peroxisomal b-oxidation. The remaining homogenates were centrifuged at 18000ϫg for 20 min, and the supernatant was centrifuged under the same conditions. The supernatant was centrifuged at 105000ϫg for 60 min. The pellet was resuspended in 0.25 M sucrose/0.1 mM EDTA/10 mM Tris-HCl (pH 7.4) and recentrifuged under the same conditions. The resulting pellet was resuspended in a small volume of 0.25 M sucrose/0.1 mM EDTA/10 mM Tris-HCl (pH 7.4) and used as microsomes. All operations were carried out at 0-4°C. Protein concentrations were determined by the method of Lowry et al. 16 ) using bovine serum albumin as a standard. All animal studies complied with the institutional board for animal studies, Josai University.
Enzyme Assays Peroxisomal b-oxidation was assayed with palmitoyl-CoA as a substrate by the method of Lazarow and de Duve 17) with some miner modifications. 18) Homogenates were used as an enzyme source. Microsomal 1-acyl-GPC acyltransferase was assayed with oleoyl-CoA as substrate by the method of Lands and Hart 19) as described previously.
20)
Determination of PFCAs After adding an internal standard, PFCAs were extracted from liver homogenates as an ion pair with tetrabutylammonium, derivatized with 3-bromoacetyl-7-methoxycoumarin and quantified by reverse-phase HPLC with a fluorescent detector as described previously. 15) PFHeA was used as an internal standard for the determination of PFHA and PFOA; PFHA was for the determination of PFNA; PFOA was for the determination of PFHeA.
Statistical Analyses Homogeneity of variance was established using one-way analysis of variance. When a difference was significant (pϽ0.05), Schéffe's multiple range test was used as a post-test. Statistical significance between two means was estimated by either Student's t-test or Welch's test after F-test. Linear regression analysis was performed to evaluate the correlation between two means.
RESULTS
Effects of PFCAs on Body Weight and Relative Liver
Weight of Mice Male and female ddY mice were intraperitoneally injected with PFHeA, PFHA, PFOA or PFNA once a day for 5 d. The treatments did not significantly affect the growth of mice (Table 1) , and the other animals survived throughout the treatment with PFCAs without untoward response. PFHA, PFOA and PFNA caused enlargement of the liver in a dose-dependent manner (Table 1) . PFOA and PFNA induced hepatomegaly more significantly than PFHA did. PFHeA slightly increased liver weight in female mice. Based on the results presented in Table 1 , the doses, which are required to increase relative liver weight 1.5 times over the control, of PFHeA, PFHA, PFOA and PFNA were approximately Ͼ150, 40, 2.5 and 2.5 mg/kg of body weight for male mice and Ͼ150, 100, 7.5 and 2.5 mg/kg of body weight for female mice, respectively. Sex-related difference was slightly observed in the induction of hepatomegaly by PFHA and PFOA (Table 1) .
Effects of PFCAs on Peroxisomal b b-Oxidation and Microsomal 1-Acyl-GPC Acyltransferase in the Liver The activity of peroxisomal b-oxidation was increased in a dosedependent manner by the administration of all the PFCAs tested (Fig. 1) . The treatment of mice with PFOA or PFNA potently increased the activity of peroxisomal b-oxidation. The induction by PFOA and PFNA was saturable, and the maximum activity was calculated to be approximately 106 nmol/min/mg protein. Compared to PFOA and PFNA, PFHA required much higher doses to induce peroxisomal boxidation. The amount of PFHA that was required to increase the activity to 50% of the maximally induced activity was 75 and 100 mg/kg of body weight in male and female mice, respectively. The administration of PFHA at a dose of 150 mg/kg of body weight resulted in death of 50% of mice (unpublished results). The administration of PFHeA at the doses over 100 mg/kg of body weight to mice caused a slight, but a significant, increase in the activity. The doses, which were required to induce peroxisomal b-oxidation to 20% of the maximally induced activity, of PFNA, PFOA, PFHA and PFHeA were calculated from the dose-response curve presented in Fig. 2 to be 0.7, 0.8, 11 and 84 mg/kg of body weight for male mice and, 0.7, 0.9, 30 and 150 mg/kg of body weight for female mice, respectively. It should be noted here that there was no significant difference in the induction by the PFCAs examined between male and female mice except for PFHA.
Effects of the treatment of male mice with PFHeA, PFHA, PFOA and PFNA on microsomal 1-acyl-GPC acyltransferase were examined (Fig. 2) . The administration of PFOA and PFNA at the doses of 20 mg/kg of body weight to male mice markedly induced 1-acyl-GPC acyltransferase; PFHA at a dose of 100 mg/kg of body weight induced the enzyme, with the extent of the induction being not as marked as those observed with PFOA and PFNA. The treatment of mice with PFHeA at a dose of 150 mg/kg of body weight slightly increased the activity, but the increase was not statistically significant. A linear regression analysis revealed one linear regression line for 5 sets of mean data of Figs. 1 and 2, with a high correlation being seen between the two parameters (rϭ0.985, pϽ0.01) (Fig. 3) . (Fig. 4) . The concentrations of PFHeA in the liver were lower than 3 nmol/g liver in both male and female mice at all doses examined (data not shown). Dose-dependent accumulation was observed with PFHA, PFOA and PFNA in the liver of male mice; hepatic concentrations of PFHA and PFOA were calculated to be 0.8 and 56.6%, respectively, of that of PFNA, when compared at a dose of 20 mg/kg body weight. A dose-dependent accumulation was observed with PFHA, PFOA and PFNA in the liver of female mice as was found in male mice. However, the concentrations of PFHA, PFOA and PFNA in the liver of female mice were significantly lower than those in male mice; the concentrations in the liver of female mice were 17.5%, 64% and 69.5% of those of male mice, respectively, when compared at the dose of 20 mg/kg of body weight. a-e Differences between the values at different doses are statistically significant without a common superscript in male mice (p<0.05).
Accumulation of PFCAs in the Liver
x-z,v,w Differences between the values at different doses are statistically significant without a common superscript in female mice (p<0.05). The relationship between the activity of peroxisomal b-oxidation (data from Fig. 1 ) and the activity of microsomal 1-acyl-GPC acyltransferase (data from Fig. 2 ) was determined as Yϭ1.573Xϩ54.550 (rϭ0.9935, pϽ0.001).
erators are known to induce hepatomegaly and peroxisomal b-oxidation in the liver of rodents as common properties 21) and are considered to cause biochemical responses through the activation of peroxisome proliferator-activated receptor (PPAR) a. 22) With regard to microsomal 1-acyl-GPC acyltransferase, the gene responsible for this enzyme has not been cloned yet, so that it is still uncertain whether 1-acyl-GPC acyltransferase is under the control of PPARa. However, since the previous study demonstrated that microsomal 1-acyl-GPC acyltransferase was induced by the treatment of rats with peroxisome proliferators having diverse chemical structures, suggesting that microsomal 1-acyl-GPC acyltransferase is suitable as a parameter to estimate the response of the liver to the challenge with peroxisome proliferators. 20) The present study demonstrated that the administration of PFCAs having 6-9 carbon chain length significantly induced hepatomegaly, peroxisomal b-oxidation and microsomal 1-acyl-GPC acyltransferase in the liver of both male and female mice, in the order of PFNAՆPFOAϾPFHAϾ PFHeA. The doses, which were required to increase the activity of peroxisomal b-oxidation to 20% of the maximally induced activity, of PFNA, PFOA, PFHA and PFHeA were 0.7, 0.8, 11.2 and 84 mg/kg of body weight in male mice and 0.7, 0.9, 30 and 150 mg/kg of body weight in female mice, respectively.
From a toxicological point of view, it is important to understand the mechanism by which PFCA having shorter carbon chain length causes hepatic response to a less extent. The recent study demonstrated that PFOA as well as other peroxisome proliferators activated PPARa to induce PPARa target genes of enzymes including peroxisomal b-oxidation, utilizing reporter assay with the cells infected with mouse PPARa gene. 23) Accordingly, the potency of PFCA to induce peroxisomal b-oxidation in vivo depends on both its molecular potential as PPARa ligand and hepatic residual amounts. Little or no direct evidence has been provided about whether PFCAs other than PFOA are able to activate PPARa. However, the present study showed that the administration of PFHeA, PFHA and PFNA to mice induced peroxisomal boxidation in the liver, suggesting that these PFCAs are also PPARa ligands. To our knowledge, no precise information is available about the relative potency of PFCA molecules with 6-9 carbon chain length as PPARa ligand. One linear regression line was confirmed between the activities of peroxisomal b-oxidation and hepatic concentrations of PFCAs regardless of difference of perfluoroalkyl chain length. This result made us conclude that the difference in the potency in vivo to induce peroxisomal b-oxidation between PFCAs is essentially due to the different accumulation of PFCAs in the liver and that the molecular potential of these PFCAs for activating PPARa are essentially the same. Hepatic concentrations of PFHeA and PFHA were considerably lower than the concentrations that were expected based on the activity of peroxisomal b-oxidation that was calculated on the basis of the regression line between the activity of peroxisomal b-oxidation and hepatic concentrations of PFOA and PFNA. This is considered to be due to rapid clearance of PFHeA and PFHA in mice compared with PFCAs with longer carbon chain lengths and long half-life of acyl-CoA oxidase, the enzyme working in rate-limiting step of peroxisomal b-oxidation. 24 ) Namely, since hepatic concentrations of PFHA and PFHeA were measured 24 h after the final injection, there is a possibility that these two PFCAs once entered the liver, played a role in activation of PPARa, and thereafter cleared from the liver. In the previous study, the potency to induce peroxisomal b-oxidation was in the order of PFNAϾPFOAϾPFHA in the liver of male rats. 8) Moreover, the treatment with PFHeA at a dose of 160 mg/kg body weight had no effect on peroxisomal b-oxidation in the liver of male rats (unpublished results). Therefore, mice accumulate PFCA having shorter perfluoroalkyl chain more efficiently than rats do.
Sex-Related Difference in the Induction of Peroxisomal b b-Oxidation The previous study demonstrated that the treatment of male rats with PFOA increased the activity of peroxisomal b-oxidation 5 times as high as the control whereas no induction was caused by PFOA in female rats and that the evident difference in the rate of elimination of PFOA between male and female rats was responsible for this striking sex-related difference in the enzyme induction. 12, 25, 26) On the other hand, no sex-related difference has been reported in the induction of peroxisomal b-oxidation by PFOA in the liver of mice.
11) The present results showed that hepatic concentrations of PFOA in female were 60-70%, depending on the doses, of those of male mice, whereas the previous study demonstrated that PFOA accumulated substantially in the liver of male rats, but was not detected in the liver of female rats. 12) Linear regression analyses on the activities of peroxisomal b-oxidation and hepatic concentrations of PFCAs revealed that the slope of regression line for female mice is in accordance with that for male mice. Accordingly, the difference in the amounts of PFOA accumulated in the liver between female mice and female rats seems to be responsible for the striking difference observed in sexrelated difference in the induction of peroxisomal b-oxidation between mice and rats.
Toxicological Implications of PFCA Exposure The present study concluded that the longer the carbon chain length becomes, the more PFCA accumulates in the liver of mice and that the longer the perfluoroalkyl chain of PFCA, the more potent is PFCA as inducers of hepatomegaly, peroxisomal b-oxidation and microsomal 1-acyl-GPC acyltransferase. This conclusion is the same as that from the previous study where rats were used as experimental animals reached.
12) These facts, taken together, strongly suggest that shorter perfluoroalkyl chains of PFCAs equate to shorter half-lives in experimental animals. It can be generalized, therefore, that PFCAs having shorter carbon chains are less hazardous in experimental animals. Contrary to the relatively rapid rates of elimination reported in laboratory animals, 25, 26) PFOA appears to be slowly eliminated in humans.
9,27) The half-life of PFOA in human blood is estimated to exceed 4 years. 9) To our knowledge, however, little information is available about toxicokinetics and sex-related difference in the accumulation of PFCAs other than PFOA in humans. 27) 
